Augmedix (NASDAQ:AUGX) reported quarterly sales of $6.60 million which beat the analyst consensus estimate of $6.40 million by 3.13 percent.
Related Posts
Why Bellicum Pharmaceuticals (BLCM) Stock Is Down 48%
Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) shares are trading lower by 48.26% to $0.44 Wednesday morning after the company discontinued Phase 1/2 trials and initiated an evaluation of strategic alternatives.
Berry Global Plans $110M Investment To Expand North American Capacity
Berry Global Group Inc (NYSE:BERY) has announced a $110 million investment to expand its foodservice packaging manufacturing operations in North America.…